0001179110-20-008088.txt : 20200707 0001179110-20-008088.hdr.sgml : 20200707 20200707081157 ACCESSION NUMBER: 0001179110-20-008088 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200702 FILED AS OF DATE: 20200707 DATE AS OF CHANGE: 20200707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JOHNSON JOHN CENTRAL INDEX KEY: 0001410781 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37569 FILM NUMBER: 201015269 MAIL ADDRESS: STREET 1: DENDREON CORPORATION STREET 2: 1301 2ND AVENUE CITY: SEATTLE STATE: WA ZIP: 98101 FORMER NAME: FORMER CONFORMED NAME: Johnson John H DATE OF NAME CHANGE: 20070827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Strongbridge Biopharma plc CENTRAL INDEX KEY: 0001634432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981130690 STATE OF INCORPORATION: L2 BUSINESS ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: (610) 254-9200 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 FORMER COMPANY: FORMER CONFORMED NAME: Cortendo AB DATE OF NAME CHANGE: 20150219 4 1 edgar.xml FORM 4 - X0306 4 2020-07-02 0 0001634432 Strongbridge Biopharma plc SBBP 0001410781 JOHNSON JOHN 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053 1 1 0 0 Chief Executive Officer Ordinary Shares 2020-07-02 4 A 0 315000 0 A 522152 D Represents a grant of restricted stock units ("RSUs"). One-half of the RSUs will vest on July 2, 2021 with the remaining one-half of the RSUs vesting on July 2, 2022, provided the Reporting Person is employed by, or providing services to, the Issuer on each vesting date. Each RSU represents a contingent right to receive one ordinary share of the Issuer. /s/ Judith Goldberg, as attorney-in-fact 2020-07-07